Elevated serum creatinine or hyperkalemia after ACEi/ARB
Estimate risk of elevated serum creatinine or hyperkalemia after ACEi or ARB initiation
Questions
About
Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) can increase the risk of kidney dysfunction and hyperkalemia. This calculator estimates the short-term risk of an increase in serum potassium to >5.5 mmol/L, a 30% increase in serum creatinine, or both within 30 days of ACEi or ARB initiation.
This equation was derived in two retrospective, population-based cohorts of adults in North America.
References
Parikh RV, Nash DM, et. al.
By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.